HOME Top Market Reports Active Pharmaceutical Ingredients/API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD) - Global Forecast to 2021

Active Pharmaceutical Ingredients/API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: January 2017
Report Code: PH 1262

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global active pharmaceutical ingredients market is expected to reach USD 213.97 Billion by 2021 from USD 157.95 Billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021. The factors driving market growth include increasing incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries may restrain the market growth.

On the basis of type, the market is segmented into innovative and generic APIs. The innovative APIs segment is estimated to command the largest share in 2016. Some of the major factors contributing to its large share include growing demand for innovative therapeutics for treatment of dreadful diseases, especially cancer , the increase in the number of FDA approvals for new molecular entities and the higher prices of innovative APIs (as compared to generics). On the basis of type of synthesis, the market is segmented into synthetic and biotech APIs.

North America dominates the active pharmaceutical ingredients market, with the U.S. accounting for the major share. This can be attributed to the increase in the increasing incidence of chronic diseases, increasing focus of the government on the growing adoption of generic drugs, rising demand for biologics and specialty drugs, and technological advances in API manufacturing in this region.

The prominent players in the active pharmaceutical ingredients market are Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (U.S.), GlaxoSmithKline plc (U.K.), Merck & Co., Inc. (U.S.) and AbbVie Inc. (U.S.).

Market Stakeholders:

  • Medical image management software providers
  • Diagnostic imaging equipment vendors/service providers
  • Standalone image management software/workstation providers
  • Healthcare IT service providers
  • Research and consulting firms
  • Diagnostic imaging centers
  • Hospitals
  • Venture capitalists
  • Government agencies
  • Market research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

The research report categorizes the active pharmaceutical ingredients market into the following segments and subsegments:

  • APIs Market, by Type
    • Innovative APIs
    • Generic APIS
  • APIs Market, by Type of Manufacturer
    • Captive Manufacturers
    • Merchant Manufacturers
      • Merchant Manufacturers Market, by Type
        • Innovative Merchant API Manufacturers
        • Generic Merchant API Manufacturers
      • Merchant Manufacturers Market, by Type of Synthesis
        • Synthetic APIs
        • Biotech APIs
  • APIs market, by Type of Synthesis
    • Synthetic APIs Market
      • Synthetic APIs Market, by Type
        • Innovative Synthetic APIs
        • Generic Synthetic APIs
    • Biotech APIs Market
      • Biotech APIs Market, by Type
        • Innovative Biotech APIs
        • Biosimilars
      • Biotech APIs Market, by Product
        • Monoclonal Antibodies
        • Hormones
        • Cytokines
        • Fusion Proteins
        • Therapeutic Enzymes
        • Vaccines
        • Blood Factors
      • Biotech APIs Market, by Expression System
        • Mammalian Expression Systems
        • Microbial Expression Systems
        • Yeast Expression Systems
        • Insect Expression Systems
        • Plant Expression Systems
        • Other Expression Systems
  • APIs Market, by Type of Drug
    • Prescription Drugs
    • Over-the-counter Drugs
  • APIs Market, by Therapeutic Application
    • Oncology
    • Diabetes
    • Cardiovascular Disease
    • CNS and Neurological Disorders
    • Endocrinology
    • Other Therapeutic Applications (Orthopedics, Urology and Nephrology, Ophthalmology, Pulmonology, Women’s Health, and Gastroenterology)
  • API Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • Asia
      • Japan
      • China
      • India
      • South Korea
      • Rest of Asia (RoA)
    • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Geographic Analysis

  • Further breakdown of the Rest of the World medical imaging management market into Pacific countries, the Middle East and Africa (MEA), and Latin America (LATAM)

Table of Contents

1 Introduction (Page No. - 28)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Study Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 32)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Data From Secondary Sources
    2.4 Key Data From Primary Sources
    2.5 Key Industry Insights
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 41)

4 Premium Insights (Page No. - 47)
    4.1 Active Pharmaceutical Ingredients Market Overview
    4.2 Active Pharmaceutical Ingredients Market, By Type of Manufacturer
    4.3 Active Pharmaceutical Ingredients Market, By Therapeutic Area
    4.4 Biotech Active Pharmaceutical Ingredients Market, By Product
    4.5 Active Pharmaceutical Ingredients Market, By Type of Drug
    4.6 Active Pharmaceutical Ingredients Market: Geographic Snapshot

5 Market Overview (Page No. - 52)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Incidence of Chronic Diseases
                    5.2.1.2 Rising Prevalence of Cancer
                    5.2.1.3 Technological Advancements in API Manufacturing
                    5.2.1.4 Growing Importance of Generics
                    5.2.1.5 Rapidly Increasing Geriatric Population
                    5.2.1.6 Increase in Abbreviated New Drug Applications (ANDA)
                    5.2.1.7 Increasing Uptake of Biopharmaceuticals
           5.2.2 Restraints
                    5.2.2.1 Stringent Regulatory Requirements
                    5.2.2.2 Unfavorable Drug Price Control Policies Across Various Countries
           5.2.3 Opportunities
                    5.2.3.1 Emerging Biosimilars Market
                    5.2.3.2 Increasing Scope for High-Potency Active Pharmaceutical Ingredients
                    5.2.3.3 Emerging Markets
                    5.2.3.4 Emerging Technologies
           5.2.4 Challenges
                    5.2.4.1 Product Differentiation
                    5.2.4.2 High Manufacturing Costs

6 Active Pharmaceutical Ingredients Market, By Type (Page No. - 64)
    6.1 Introduction
    6.2 Innovative Active Pharmaceutical Ingredients
    6.3 Generic Active Pharmaceutical Ingredients

7 Active Pharmaceutical Ingredients Market, By Type of Manufacturer (Page No. - 73)
    7.1 Introduction
    7.2 Captive Manufacturers
    7.3 Merchant API Manufacturers
           7.3.1 Merchant Manufacturers Market, By Type
                    7.3.1.1 Innovative Merchant API Manufacturers
                    7.3.1.2 Generic Merchant API Manufacturers
           7.3.2 Merchant API Manufacturers Market, By Mode of Synthesis
                    7.3.2.1 Synthetic APIs
                    7.3.2.2 Biotech APIs

8 Active Pharmaceutical Ingredients Market, By Type of Synthesis (Page No. - 92)
    8.1 Introduction
    8.2 Synthetic Active Pharmaceutical Ingredients
           8.2.1 Synthetic Active Pharmaceutical Ingredients Market, By Type
                    8.2.1.1 Innovative Synthetic APIs
                    8.2.1.2 Generic Synthetic APIs
    8.3 Biotech Active Pharmaceutical Ingredients
           8.3.1 Biotech Active Pharmaceutical Ingredients Market, By Type
                    8.3.1.1 Innovative Biotech APIs
                    8.3.1.2 Biosimilars
           8.3.2 Biotech Active Pharmaceutical Ingredients Market, By Product
                    8.3.2.1 Monoclonal Antibodies
                    8.3.2.2 Vaccines
                    8.3.2.3 Hormones and Growth Factors
                    8.3.2.4 Cytokines
                    8.3.2.5 Fusion Proteins
                    8.3.2.6 Therapeutic Enzymes
                    8.3.2.7 Blood Factors
           8.3.3 Biotech Active Pharmaceutical Ingredients Market, By Expression System
                    8.3.3.1 Mammalian Expression Systems
                    8.3.3.2 Microbial Expression Systems
                    8.3.3.3 Yeast Expression Systems
                    8.3.3.4 Plant Expression Systems
                    8.3.3.5 Insect Expression Systems

9 Active Pharmaceutical Ingredients Market, By Type of Drug (Page No. - 138)
    9.1 Introduction
    9.2 Prescription Drugs
    9.3 Over-The-Counter Drugs
    9.4 Active Pharmaceutical Ingredients Market, By Potency
           9.4.1 Low to Moderate Potency Active Pharmaceutical Ingredients
           9.4.2 Potent to Highly Potent Active Pharmaceutical Ingredients

10 Active Pharmaceutical Ingredients Market, By Therapeutic Application (Page No. - 148)
     10.1 Introduction
     10.2 Oncology
     10.3 Cardiovascular Disease
     10.4 Diabetes
     10.5 Central Nervous System and Neurological Disorders
     10.6 Endocrinology
     10.7 Other Therapeutic Applications

11 Active Pharmaceutical Ingredients Market, By Region (Page No. - 166)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe (RoE)
     11.4 Asia
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 South Korea
             11.4.5 Rest of Asia (RoA)
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 262)
     12.1 Overview
     12.2 Market Player Ranking
     12.3 Competitive Situation and Trends
             12.3.1 Agreements, Collaborations, Partnerships, Joint Ventures, and Alliances
             12.3.2 Regulatory Approvals
             12.3.3 Mergers and Acquisitions
             12.3.4 Expansions
             12.3.5 Investments

13 Company Profiles (Page No. - 270)
(Overview, Financials, Products & Services, Strategy, and Developments)*
     13.1 Introduction
     13.2 Pfizer, Inc.
     13.3 Novartis International AG
     13.4 Sanofi
     13.5 Boehringer Ingelheim
     13.6 Bristol-Myers Squibb
     13.7 Teva Pharmaceutical Industries Ltd.
     13.8 ELI Lilly and Company
     13.9 Glaxosmithkline PLC
     13.10 Merck & Co., Inc.
     13.11 Abbvie Inc.

*Details on Overview, Financials, Product & Services, Strategy, and Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 296)
     14.1 Insights From Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.6 Available Customizations
     14.7 Related Reports
     14.8 Author Details


List of Tables (369 Tables)

Table 1 Indicative List of Generic Drugs That Gained Approval in 2016
Table 2 Statistics on Aging Population
Table 3 Indicative List of Biologics That Gained U.S. Regulatory Approval in 2015–2016
Table 4 Increasing Incidence of Chronic Diseases: A Major Market Driver
Table 5 Stringent Regulatory Requirements: A Major Restraint for Market Growth
Table 6 Emerging Markets Offer Significant Growth Opportunities
Table 7 Stringent Regulatory Guidelines: A Major Challenge for Market Growth
Table 8 Active Pharmaceutical Ingredients Market Size, By Type, 2014-2021 (USD Billion)
Table 9 Indicative List of New Molecular Entities That Gained U.S. Fda Approval in 2016
Table 10 Significant Patent Expiries, 2015
Table 11 Innovative Active Pharmaceutical Ingredients Market Size, By Region, 2014-2021 (USD Billion)
Table 12 North America: Innovative Active Pharmaceutical Ingredients Market Size, By Country, 2014-2021 (USD Billion)
Table 13 Europe: Innovative Active Pharmaceutical Ingredients Market Size, By Country, 2014-2021 (USD Billion)
Table 14 Asia: Innovative Active Pharmaceutical Ingredients Market Size, By Country, 2014-2021 (USD Billion)
Table 15 Generic Active Pharmaceutical Ingredients Market, By Region, 2014-2021 (USD Billion)
Table 16 North America: Generic Active Pharmaceutical Ingredients Market Size, By Country, 2014-2021 (USD Billion)
Table 17 Europe: Generic Active Pharmaceutical Ingredients Market Size, By Country, 2014-2021 (USD Billion)
Table 18 Asia: Generic Active Pharmaceutical Ingredients Market Size, By Country, 2014-2021 (USD Billion)
Table 19 Active Pharmaceutical Ingredients Market Size, By Type of Manufacturer, 2014–2021 (USD Billion)
Table 20 Captive API Manufacturers Market Size, By Region, 2014–2021 (USD Billion)
Table 21 North America: Captive API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 22 Europe: Captive API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 23 Asia: Captive API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 24 List of Significant Mergers and Acquisitions in the Cmo/Cdmo Industry
Table 25 List of Significant Cmo/Cdmo Facility Expansions
Table 26 Merchant API Manufacturers Market Size, By Region, 2014–2021 (USD Billion)
Table 27 North America: Merchant API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 28 Europe: Merchant API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 29 Asia: Merchant API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 30 Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 31 Innovative Merchant API Manufacturers Market Size, By Region, 2014–2021 (USD Billion)
Table 32 North America: Innovative Merchant API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 33 Europe: Innovative Merchant API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 34 Asia: Innovative Merchant API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 35 Generic Merchant API Manufacturers Market Size, By Region, 2014–2021 (USD Billion)
Table 36 North America: Generic Merchant API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 37 Europe: Generic Merchant API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 38 Asia: Generic Merchant API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 39 Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 40 Merchant Synthetic API Manufacturers Market Size, By Region, 2014–2021 (USD Billion)
Table 41 North America: Merchant Synthetic API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 42 Europe: Merchant Synthetic API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 43 Asia: Merchant Synthetic API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 44 Merchant Biotech API Manufacturers Market Size, By Region, 2014–2021 (USD Billion)
Table 45 North America: Merchant Biotech API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 46 Europe: Merchant Biotech API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 47 Asia: Merchant Biotech API Manufacturers Market Size, By Country, 2014–2021 (USD Billion)
Table 48 Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2014–2021 (USD Billion)
Table 49 Synthetic Active Pharmaceutical Ingredients Market Size, By Region, 2014–2021 (USD Billion)
Table 50 North America: Synthetic Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 51 Europe: Synthetic Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 52 Asia: Synthetic Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 53 Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 54 Innovative Synthetic Active Pharmaceutical Ingredients Market Size, By Region, 2014–2021 (USD Billion)
Table 55 North America: Innovative Synthetic Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 56 Europe: Innovative Synthetic Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 57 Asia: Innovative Synthetic Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 58 Generic Synthetic Active Pharmaceutical Ingredients Market Size, By Region, 2014–2021 (USD Billion)
Table 59 North America: Generic Synthetic Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 60 Europe: Generic Synthetic Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 61 Asia: Generic Synthetic Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 62 Top Selling Biologics (2015)
Table 63 Biotech Active Pharmaceutical Ingredients Market Size, By Region, 2014–2021 (USD Billion)
Table 64 North America: Biotech Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 65 Europe: Biotech Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 66 Asia: Biotech Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 67 Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 68 Innovative Biotech Active Pharmaceutical Ingredients Market Size, By Region, 2014–2021 (USD Billion)
Table 69 North America: Innovative Biotech Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 70 Europe: Innovative Biotech Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 71 Asia: Innovative Biotech Active Pharmaceutical Ingredients Market Size, By Country, 2014–2021 (USD Billion)
Table 72 Biosimilars Market Size, By Region, 2014–2021 (USD Billion)
Table 73 North America: Biosimilars Market Size, By Country, 2014–2021 (USD Billion)
Table 74 Europe: Biosimilars Market Size, By Country, 2014–2021 (USD Billion)
Table 75 Asia: Biosimilars Market Size, By Country, 2014–2021 (USD Billion)
Table 76 Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Billion)
Table 77 Indicative List of Monoclonal Antibodies That Received Fda Approval in 2016
Table 78 Monoclonal Antibodies Market Size, By Region, 2014–2021 (USD Billion)
Table 79 North America: Monoclonal Antibodies Market Size, By Country, 2014–2021 (USD Billion)
Table 80 Europe: Monoclonal Antibodies Market Size, By Country, 2014–2021 (USD Billion)
Table 81 Asia: Monoclonal Antibodies Market Size, By Country, 2014–2021 (USD Billion)
Table 82 Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 83 North America: Vaccines Market Size, By Country, 2014–2021 (USD Million)
Table 84 Europe: Vaccines Market Size, By Country, 2014–2021 (USD Million)
Table 85 Asia: Vaccines Market Size, By Country, 2014–2021 (USD Million)
Table 86 Hormones and Growth Factors Market Size, By Region, 2014–2021 (USD Billion)
Table 87 North America: Hormones and Growth Factors Market Size, By Country, 2014–2021 (USD Billion)
Table 88 Europe: Hormones and Growth Factors Market Size, By Country, 2014–2021 (USD Billion)
Table 89 Asia: Hormones and Growth Factors Market Size, By Country, 2014–2021 (USD Billion)
Table 90 Cytokines Market Size, By Region, 2014–2021 (USD Billion)
Table 91 North America: Cytokines Market Size, By Country, 2014–2021 (USD Billion)
Table 92 Europe: Cytokines Market Size, By Country, 2014–2021 (USD Million)
Table 93 Asia: Cytokines Market Size, By Country, 2014–2021 (USD Million)
Table 94 Fusion Proteins Market Size, By Region, 2014–2021 (USD Billion)
Table 95 North America: Fusion Proteins Market Size, By Country, 2014–2021 (USD Billion)
Table 96 Europe: Fusion Proteins Market Size, By Country, 2014–2021 (USD Million)
Table 97 Asia: Fusion Proteins Market Size, By Country, 2014–2021 (USD Million)
Table 98 Therapeutic Enzymes Market Size, By Region, 2014–2021 (USD Billion)
Table 99 North America: Therapeutic Enzymes Market Size, By Country, 2014–2021 (USD Million)
Table 100 Europe: Therapeutic Enzymes Market Size, By Country, 2014–2021 (USD Million)
Table 101 Asia: Merchant Therapeutic Enzymes Market Size, By Country, 2014–2021 (USD Million)
Table 102 Blood Factors Market Size, By Region, 2014–2021 (USD Million)
Table 103 North America: Blood Factors Market Size, By Country, 2014–2021 (USD Million)
Table 104 Europe: Blood Factors Market Size, By Country, 2014–2021 (USD Million)
Table 105 Asia: Blood Factors Market Size, By Country, 2014–2021 (USD Million)
Table 106 Biotech Active Pharmaceutical Ingredients Market Size, By Expression System, 2014–2021 (USD Billion)
Table 107 Mammalian Expression Systems Market Size, By Region, 2014–2021 (USD Billion)
Table 108 North America: Mammalian Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 109 Europe: Mammalian Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 110 Asia: Mammalian Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 111 Microbial Expression Systems Market Size, By Region, 2014–2021 (USD Billion)
Table 112 North America: Microbial Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 113 Europe: Microbial Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 114 Asia: Microbial Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 115 Yeast Expression Systems Market Size, By Region, 2014–2021 (USD Billion)
Table 116 North America: Yeast Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 117 Europe: Yeast Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 118 Asia: Yeast Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 119 Plant Expression Systems Market Size, By Region, 2014–2021 (USD Billion)
Table 120 North America: Plant Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 121 Europe: Plant Expression Systems Market Size, By Country, 2014–2021 (USD Million)
Table 122 Asia: Other Expression Systems Market Size, By Country, 2014–2021 (USD Million)
Table 123 Insect Expression Systems Market Size, By Region, 2014–2021 (USD Billion)
Table 124 North America: Insect Expression Systems Market Size, By Country, 2014–2021 (USD Billion)
Table 125 Europe: Insect Expression Systems Market Size, By Country, 2014–2021 (USD Million)
Table 126 Asia: Insect Expression Systems Market Size, By Country, 2014–2021 (USD Million)
Table 127 Global Market Size, By Type of Drug, 2014–2021 (USD Billion)
Table 128 Global Market Size for Prescription Drugs, By Region, 2014–2021 (USD Billion)
Table 129 North America: Market Size for Prescription Drugs By Country, 2014–2021 (USD Billion)
Table 130 Europe: Market Size for Prescription Drugs By Country, 2014–2021 (USD Billion)
Table 131 Asia: Market Size for Prescription Drugs Country, 2014–2021 (USD Billion)
Table 132 Prescription-To-Otc Switch List in the U.S.
Table 133 Global Market Size for Over-The-Counter Drugs, By Region, 2014–2021 (USD Billion)
Table 134 North America: Market Size for Over-The-Counter Drugs By Country, 2014–2021 (USD Billion)
Table 135 Europe: Market Size for Over-The-Counter Drugs By Country, 2014–2021 (USD Billion)
Table 136 Asia: Market Size for Over-The-Counter Drugs By Country, 2014–2021 (USD Billion)
Table 137 Active Pharmaceutical Ingredients Market Size, By Potency, 2014-2021 (USD Billion)
Table 138 Active Pharmaceutical Ingredients Market Size, By Therapeutic Application, 2014–2021 (USD Billion)
Table 139 Cancer: Estimated Incidence, Mortality, and Prevalence (2012)
Table 140 Active Pharmaceutical Ingredients Market Size for Oncology, By Region, 2014–2021 (USD Billion)
Table 141 North America: Market Size for Oncology By Country, 2014–2021 (USD Billion)
Table 142 Europe: Market Size for Oncology By Country, 2014–2021 (USD Billion)
Table 143 Asia: Market Size for Oncology By Country, 2014–2021 (USD Billion)
Table 144 Active Pharmaceutical Ingredients Market Size for Cvd, By Region, 2014–2021 (USD Billion)
Table 145 North America: Active Pharmaceutical Ingredients Market Size for Cvd, By Country, 2014–2021 (USD Billion)
Table 146 Europe: Market Size for Cvd, By Country 2014–2021 (USD Billion)
Table 147 Asia: Active Pharmaceutical Ingredients Market Size for Cvd, By Country, 2014–2021 (USD Billion)
Table 148 Active Pharmaceutical Ingredients Market Size for Diabetes, By Region, 2014–2021 (USD Billion)
Table 149 North America: Market Size for Diabetes By Country, 2014–2021 (USD Billion)
Table 150 Europe: Market Size for Diabetes By Country, 2014–2021 (USD Billion)
Table 151 Asia: Market Size for Diabetes By Country, 2014–2021 (USD Billion)
Table 152 Active Pharmaceutical Ingredients Market Size for Cns and Neurological Disorders, By Region, 2014–2021 (USD Billion)
Table 153 North America: Market Size for Cns and Neurological Disorders By Country, 2014–2021 (USD Billion)
Table 154 Europe: Market Size for Cns and Neurological Disorders By Country, 2014–2021 (USD Billion)
Table 155 Asia: Market Size for Cns and Neurological Disorders By Country, 2014–2021 (USD Billion)
Table 156 Active Pharmaceutical Ingredients Market Size for Endocrinology, By Region, 2014–2021 (USD Billion)
Table 157 North America: Market Size for Endocrinology By Country, 2014–2021 (USD Billion)
Table 158 Europe: Market Size for Endocrinology By Country, 2014–2021 (USD Billion)
Table 159 Asia: Market Size for Endocrinology By Country, 2014–2021 (USD Billion)
Table 160 Active Pharmaceutical Ingredients Market Size for Other Therapeutic Applications, By Region, 2014–2021 (USD Billion)
Table 161 North America: Market Size for Other Therapeutic Applications, By Country, 2014–2021 (USD Billion)
Table 162 Europe: Market Size for Other Therapeutic Applications By Country, 2014–2021 (USD Billion)
Table 163 Asia: Market Size for Other Therapeutic Applications By Country, 2014–2021 (USD Billion)
Table 164 Global Market Size By Region, 2014–2021 (USD Billion)
Table 165 North America: Market Size By Country, 2014–2021 (USD Billion)
Table 166 North America: Market Size By Type, 2014–2021 (USD Billion)
Table 167 North America: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 168 North America: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 169 North America: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 170 North America: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 171 North America: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 172 North America: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 173 North America: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Billion)
Table 174 North America: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Billion)
Table 175 North America: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 176 North America: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 177 Recent Fda Approvals for NDA and ANDA
Table 178 U.S.: Market Size By Type, 2014–2021 (USD Billion)
Table 179 U.S.: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 180 U.S.: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 181 U.S.: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 182 U.S.: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 183 U.S.: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 184 U.S.: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 185 U.S.: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Billion)
Table 186 U.S.: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Billion)
Table 187 U.S.: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 188 U.S.: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 189 Canada: Market Size By Type, 2014–2021 (USD Billion)
Table 190 Canada: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 191 Canada: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 192 Canada: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 193 Canada: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 194 Canada: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 195 Canada: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 196 Canada: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 197 Canada: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Billion)
Table 198 Canada: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 199 Canada: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 200 Europe: Market Size By Type, 2014–2021 (USD Billion)
Table 201 Europe: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 202 Europe: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 203 Europe: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 204 Europe: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 205 Europe: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 206 Europe: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 207 Europe: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Billion)
Table 208 Europe: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Billion)
Table 209 Europe: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 210 Europe: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 211 Germany: Market Size By Type, 2014–2021 (USD Billion)
Table 212 Germany: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 213 Germany: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 214 Germany: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 215 Germany: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 216 Germany: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 217 Germany: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 218 Germany: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 219 Germany: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Billion)
Table 220 Germany: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 221 Germany: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 222 France: Market Size By Type, 2014–2021 (USD Billion)
Table 223 France: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 224 France: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 225 France: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 226 France: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 227 France: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 228 France: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 229 France: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 230 France: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Billion)
Table 231 France: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 232 France: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 233 U.K.: Market Size By Type, 2014–2021 (USD Billion)
Table 234 U.K.: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 235 U.K.: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 236 U.K.: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 237 U.K.: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 238 U.K.: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 239 U.K.: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 240 U.K.: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 241 U.K.: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Million)
Table 242 U.K.: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 243 U.K.: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 244 Italy: Market Size By Type, 2014–2021 (USD Billion)
Table 245 Italy: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 246 Italy: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 247 Italy: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 248 Italian: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 249 Italy: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 250 Italy: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 251 Italy: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 252 Italy: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Million)
Table 253 Italy: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 254 Italy: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 255 Spain: Market Size By Type, 2014–2021 (USD Billion)
Table 256 Spain: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 257 Spain: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 258 Spain: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 259 Spain: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 260 Spain: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 261 Spain: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 262 Spain: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 263 Spain: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Million)
Table 264 Spain: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 265 Spain: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 266 RoE: Market Size By Type, 2014–2021 (USD Billion)
Table 267 RoE: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 268 RoE: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 269 RoE: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 270 RoE: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 271 RoE: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 272 RoE: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 273 RoE: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 274 RoE: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Million)
Table 275 RoE: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 276 RoE: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 277 Asia: Market Size By Type, 2014–2021 (USD Billion)
Table 278 Asia: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 279 Asia: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 280 Asia: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 281 Asia: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 282 Asia: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 283 Asia: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 284 Asia: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 285 Asia: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Billion)
Table 286 Asia: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 287 Asia: Active Pharmaceutical Ingredients Market Size, By Therapeutic Application, 2014–2021 (USD Billion)
Table 288 Japan: Market Size By Type, 2014–2021 (USD Billion)
Table 289 Japan: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 290 Japan: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 291 Japan: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 292 Japan: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 293 Japan: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 294 Japan: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 295 Japan: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 296 Japan: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Million)
Table 297 Japan: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 298 Japan: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 299 China: Market Size By Type, 2014–2021 (USD Billion)
Table 300 China: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 301 China: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 302 China: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 303 China: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 304 China: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 305 China: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 306 China: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 307 China: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Million)
Table 308 China: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 309 China: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 310 India: Market Size By Type, 2014–2021 (USD Billion)
Table 311 Indian: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 312 India: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 313 India: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 314 India: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 315 India: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 316 India: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 317 India: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 318 India: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Million)
Table 319 India: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 320 India: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 321 South Korea: Market Size By Type, 2014–2021 (USD Billion)
Table 322 South Korea: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 323 South Korea: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 324 South Korea: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 325 South Korea: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 326 South Korea: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 327 South Korea: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 328 South Korea: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 329 South Korea: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Million)
Table 330 South Korea: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 331 South Korea: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 332 RoA: Market Size By Type, 2014–2021 (USD Billion)
Table 333 RoA: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 334 RoA: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 335 RoA: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 336 RoA: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 337 RoA: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 338 RoA: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 339 RoA: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 340 RoA: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Million)
Table 341 RoA: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 342 RoA: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 343 RoW: Market Size By Type, 2014–2021 (USD Billion)
Table 344 RoW: Market Size By Type of Manufacturer, 2014–2021 (USD Billion)
Table 345 RoW: Merchant API Manufacturers Market Size, By Type, 2014–2021 (USD Billion)
Table 346 RoW: Merchant API Manufacturers Market Size, By Mode of Synthesis, 2014–2021 (USD Billion)
Table 347 RoW: Market Size By Mode of Synthesis, 2014–2021 (USD Billion)
Table 348 RoW: Synthetic Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 349 RoW: Biotech Active Pharmaceutical Ingredients Market Size, By Type, 2014–2021 (USD Billion)
Table 350 RoW: Biotech Active Pharmaceutical Ingredients Market Size, By Product, 2014–2021 (USD Million)
Table 351 RoW: Biotech Active Pharmaceutical Ingredients Market Size, By Type of Expression System, 2014–2021 (USD Billion)
Table 352 RoW: Market Size By Type of Drug, 2014–2021 (USD Billion)
Table 353 RoW: Market Size By Therapeutic Application, 2014–2021 (USD Billion)
Table 354 Agreements, Collaborations, Partnerships, Joint Ventures, and Alliances (2013–2016)
Table 355 Regulatory Approvals (2013-2016)
Table 356 Mergers and Acquisitions (2013-2016)
Table 357 Expansions (2013–2016)
Table 358 Investments (2013–2016)
Table 359 Exchange Rate (Utilized for the Conversion of Eur to USD)
Table 360 Exchange Rate (Utilized for the Conversion of Gbp to USD)
Table 361 Pfizer Inc. (U.S.)
Table 362 Novartis International AG (Switzerland)
Table 363 Sanofi (France)
Table 364 Boehringer Ingelheim (Germany)
Table 365 Bristol-Myers Squibb (U.S.)
Table 366 Teva Pharmaceutical Industries Ltd. (Israel)
Table 367 Glaxosmithkline PLC (U.K.)
Table 368 Merck & Co., Inc. (U.S.)
Table 369 Abbvie (U.S.)


List of Figures (46 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Active Pharmaceutical Ingredients Market Size, By Type, 2016 vs 2021
Figure 7 Market Size By Type of Manufacturer, 2016 vs 2021
Figure 8 Active Pharmaceutical Ingredients Market Size, By Type of Synthesis, 2016 vs 2021
Figure 9 Biotech Active Pharmaceuticals Ingredients Market Size, By Product: Monoclonal Antibodies to Dominate the Market in 2016
Figure 10 Active Pharmaceutical Ingredients Market Size, By Therapeutic Application, 2016 vs 2021
Figure 11 Geographic Snapshot of the Active Pharmaceutical Ingredients Market
Figure 12 Growing Importance of Generics, the Major Factor Driving the Growth of the Market
Figure 13 Captive Manufacturers Segment to Account for the Largest Market Share in 2016
Figure 14 Oncology Segment to Witness Highest Growth During the Forecast Period
Figure 15 Monoclonal Antibodies Segment to Witness Highest Growth During the Forecast Period
Figure 16 Over-The-Counter Drugs to Witness Highest Growth From 2016–2021
Figure 17 Asia to Witness Highest Growth in the Active Pharmaceutical Ingredients Market During the Forecast Period
Figure 18 Market Drivers, Restraints, Opportunities, and Challenges
Figure 19 Innovative Segment to Dominate the Market in 2016
Figure 20 Captive Manufacturers to Dominate the Market in 2016
Figure 21 North America to Dominate the Market for Captive Manufacturers in 2016
Figure 22 Synthetic Active Pharmaceutical Ingredients Segment to Dominate the Market in 2016
Figure 23 North America to Dominate Synthetic Active Pharmaceutical Ingredients Market in 2016
Figure 24 Prescription Drugs to Dominate the Active Pharmaceutical Ingredients Market, By Type of Drug, in 2016
Figure 25 Low to Moderate Segment to Dominate the Active Pharmaceutical Ingredients Market, By Potency, in 2016
Figure 26 Oncology Segment to Dominate the Active Pharmaceutical Ingredients Market, By Therapeutic Application
Figure 27 North America to Dominate the Oncology Active Pharmaceutical Ingredients Market, By Region
Figure 28 Asia to Witness Highest Growth During the Forecast Period (2016–2021)
Figure 29 North America to Hold the Largest Share of the Global Active Pharmaceutical Ingredients Market (2016)
Figure 30 European Active Pharmaceutical Ingredients Market Snapshot (2016)
Figure 31 Asia: Market Snapshot (2016)
Figure 32 RoW: Market Snapshot
Figure 33 Key Developments in the Active Pharmaceutical Ingredients Market, 2013–2016
Figure 34 Market Evolution Framework—Agreements, Partnerships, Collaborations, Joint Ventures, and Alliances Fueled Market Growth
Figure 35 Battle for Market Share: Agreements, Partnerships, Collaborations, Joint Ventures, and Alliances Was the Key Strategy Adopted By Market Players (2013–2016)
Figure 36 Geographic Mix of the Top 5 Players
Figure 37 Pfizer, Inc.: Company Snapshot
Figure 38 Novartis International AG: Company Snapshot
Figure 39 Sanofi: Company Snapshot
Figure 40 Boehringer Ingelheim: Company Snapshot
Figure 41 Bristol-Myers Squibb: Company Snapshot
Figure 42 Teva Pharmaceutical Industries Ltd.: Company Snapshot
Figure 43 ELI Lilly and Company: Company Snapshot
Figure 44 Glaxosmithkline PLC: Company Snapshot
Figure 45 Merck & Co., Inc.: Company Snapshot
Figure 46 Abbvie Inc.: Company Snapshot

The global active pharmaceutical ingredients market is expected to reach USD 213.97 Billion by 2021 from USD 157.95 Billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021. The market is segmented on the basis type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region.

Market growth is driven by the increasing incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals. Furthermore, emerging biosimilars market, increasing scope for HPAPIs, emerging markets and emerging technologies have opened an array of opportunities for the growth of the market. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries may restrain the growth of this market.

Based on type, the APIs market is segmented into innovative and generic APIs. The innovative APIs segment is expected to account for the largest share in 2016. The large share of this segment can be attributed to the increasing number of FDA approvals for new molecular entities, higher price commanded by innovative APIs as compared to their generic equivalents, and growing focus of innovator APIs companies on R&D for the development of novel innovative APIs products to cater to the previously unmet medical needs of the market

On the basis of type of manufacturer, the APIs market is segmented into captive and merchant manufacturers. The captive manufacturers segment is estimated to account for the largest share in 2016. The large share of this segment can be can be attributed to the growing preference of companies to maintain in-house manufacturing of innovative APIs for their economic benefits.

On the basis of type of synthesis the, the APIs market is categorized into synthetic and biotech APIs. The synthetic APIs segment is estimated to command the largest in 2016. The emergence of new molecules in the market, increasing number of new product approvals, and technological advancements in the method of synthesis are major factors contributing to the growth of the synthetic APIs segment. However, the biotech APIs segment is expected to grow at the highest CAGR in the forecast period.

The APIs market, on the basis of type of drug, is segmented into prescription drugs and over-the-counter (OTC) drugs.  In 2016, the prescription drugs segment is estimated to account for the largest share of the APIs market. The large share of this segment can primarily be attributed to the increasing demand for these drugs owing to the growing incidence of diseases such as cancer, cardiovascular disease, and respiratory disorders.

The APIs market, on the basis of therapeutic applications, is segmented into oncology, cardiovascular diseases, diabetes, endocrinology, central nervous system (CNS) and neurological disorders, and other therapeutic applications. The oncology segment is estimated to account for the largest of the global active pharmaceutical ingredients market in 2016. The large share of this segment can be attributed to the increasing incidence and prevalence of cancer globally, growing focus of pharmaceutical companies for the development of novel products for cancer treatment, and growing investments in the research activities for the development of novel therapies like targeted therapies which utilize anti-body drug conjugates for the treatment of cancer.

The global active pharmaceutical ingredients market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the global market in the forecast period. Over the next five years, Asia Is expected to register highest growth rate.

Some of the prominent players in the market include Pfizer Inc. (U.S.), Novartis International AG (Switzerland), Merck & Co. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Mylan, Inc. (U.S.), Boehringer Ingelheim (Germany), Sanofi (France), AbbVie (U.S.), Eli Lilly and Company (U.S.), AstraZeneca plc (U.K.), Bristol-Myers Squibb (U.S.), and GlaxoSmithKline plc (U.K.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Available Customizations Title

Client Consult Problem Statement :

MnM’s client who is a decentralized public entity of mixed participation (nonprofit, scientific and technical), which aims to develop and implement activities of Research, Technology and Innovation technology transfer processes in the agricultural sector and was interested in project involving “Assessment of Sapogenins paste market”. The key objective for the study involved:

  1. The market potential of Sapogenins paste (varying concentrations of hecogenin & tigogenin up to 95%) on both short & long term basis in China, Europe, USA and Mexico based on various ingredients it can substitute in Pharma, Food & other industries and thereby develop a robust strategy to penetrate into the market
  2. Market potential break up by application industry and by regions, intellectual property rights & patent analysis, value chain analysis and Porter’s Five Forces analysis
  3. Prospective customer analysis by application industry and region; annual consumption volume of existing alternatives, current issues in using the current alternatives, unmet need with respect to substitute based on parameters like price, performance, etc.

Solution Provided:
  1. Methodology Adopted by MnM : MnM carried out a detailed search of the public domain an....
  1. Methodology Adopted by MnM : MnM carried out a detailed search of the public domain and its own proprietary & non-proprietary database on sapogenins paste market to orient the project, develop the industry structure including, manufacturers/suppliers, distributors, customers, associations, regulatory authorities and allied stakeholders. Also, in-depth primary interviews with various knowledge sources were conducted to develop key information required for completing the project. Major knowledge sources were manufacturers/ suppliers of existing alternatives which sapogenins paste can substitute, other participants in the supply chain of existing alternatives, potential customers of sapogenins paste for different applications, institutions (associations, regulatory authorities, etc.), independent consultants and industry experts. These interviews were used to draw out information such as substitution potential, possible concentration of sapogenins paste, major customers, end user industry demand, customer’s activity, future growth, etc. Similarly among regulatory authorities, associations and others bodies. MnM obtained detailed information on usage trends of existing alternatives, substitution potential of sapogenins paste, regulatory approvals required, cost implications, etc. Prospective customers of sapogenins paste in application industries synthesizing derivatives, hormones, steroids, food additives, industrial applications were interviewed to understand their usage trends, adaption level, current & forecast demand, etc. MNM interviewed at least three functions in each key customers to ensure that information is complete and accurate.
  2. Actual Solution Provided: - Through the detailed outcome of the study, we provided inputs on-

    Market potential of the sapogenins paste by application industry and region. Current unmet needs with the existing alternatives were identified to estimate the market potential. Value chain analysis, cost implications and regulatory approvals analysis was provided to the client for sapogenins paste market. Prospective customer of sapogenins paste by application industry and regions were also identified with their usage trends, adaption level, and current & forecast potential demand for sapogenins paste.

Value Delivered:

MnM’s client was able to understand the market potential of Sapogenins paste on both short & long term basis in China, Europe, USA and Mexico based on various ingredients it can substitute in Pharma, Food & other industries and thereby would be able to develop a strategy to penetrate into the market. Also, the market potential was provided by application industry and region help the client to focus on the high growth applications and markets for sapogenins paste. The prospective customer analysis of sapogenins paste by application industry and regions will help the client to target them in future as their potential customers.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Pharmaceuticals Markets on KnowledgeStore
Request Demo